Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Extension Clinical Trial of Vormatrigine in Adult Patients With Epilepsy

NCT07287163 is registered in ClinicalTrials.gov with Praxis Precision Medicines as lead sponsor.

NCT NCT07287163
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07287163 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Extension Clinical Trial of Vormatrigine in Adult Patients With Epilepsy
Lead sponsor
Praxis Precision Medicines
Phase
Phase 3
Overall status
Enrolling by invitation
Start date
October 27, 2025
Completion date
December 31, 2028
Enrollment
700 (estimated)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy, tonic-clonic, focal seizure, primary generalized seizure